ICUI logo

ICU Medical, Inc. Stock Price

NasdaqGS:ICUI Community·US$3.1b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

ICUI Share Price Performance

US$125.36
-24.46 (-16.33%)
US$182.67
Fair Value
US$125.36
-24.46 (-16.33%)
31.4% undervalued intrinsic discount
US$182.67
Fair Value
Price US$125.36
AnalystConsensusTarget US$182.67

ICUI Community Narratives

AnalystConsensusTarget·
Fair Value US$182.67 31.4% undervalued intrinsic discount

Infusion Therapies And Advanced Systems Will Shape Healthcare Outcomes

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
US$182.67
31.4% undervalued intrinsic discount
Revenue
2.84% p.a.
Profit Margin
5.76%
Future PE
40.24x
Price in 2029
US$225.56

Trending Discussion

Updated Narratives

ICUI logo

ICUI: Improving Operations And 2026 Earnings Framework Are Expected To Unlock Upside

Fair Value: US$182.67 31.4% undervalued intrinsic discount
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with moderate growth potential.

2 Risks
4 Rewards

ICU Medical, Inc. Key Details

US$2.2b

Revenue

US$1.4b

Cost of Revenue

US$822.0m

Gross Profit

US$821.3m

Other Expenses

US$732.0k

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
0.03
36.84%
0.033%
60.5%
View Full Analysis

About ICUI

Founded
1984
Employees
13000
CEO
Vivek Jain
WebsiteView website
www.icumed.com

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company’s customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Recent ICUI News & Updates

Recent updates

No updates